The Melanoma Research Foundation (melanoma.org) is the world’s largest independent organization devoted to addressing melanoma, the fastest-growing form of skin cancer. The MRF supports medical research to find effective treatments and eventually a cure for melanoma, which can also occur in the eyes, in mucous membranes, and beneath fingernails and toenails. As well as educating patients and physicians about the prevention, diagnosis, and treatment of melanoma, the MRF advocates for the melanoma community and raises awareness of the disease. It urges everyone to check their skin regularly for suspicious moles or lesions and to apply sunscreen, since most melanomas are attributed to exposure to ultraviolet light. The MRF’s website is the premier source for those seeking information about melanoma.
Each charity we feature has earned a four-star overall rating from Charity Navigator, which rates not-for-profit organizations on the strength of their finances, their control of administrative and fundraising expenses, and the transparency of their operations. Four stars is the group’s highest rating.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Mountainhead: Jesse Armstrong's tech bro satire sparkles with 'weapons-grade zingers'The Week Recommends The Succession creator's first feature film lacks the hit TV show's 'dramatic richness' – but makes for a horribly gripping watch
-
Seeing Each Other: Portraits of Artists – a 'riveting' exhibitionThe Week Recommends Pallant House exhibition offers fascinating instances of painterly reciprocity
-
Geoff Dyer shares his favourite books on warThe Week Recommends Out of Sheer Rage author chooses works by Martha Gellhorn, Michael Herr and Dexter Filkins
